279 related articles for article (PubMed ID: 26656897)
21. The harmonization of quantitative test results of different D-dimer methods.
Meijer P; Kluft C
Semin Vasc Med; 2005 Nov; 5(4):321-7. PubMed ID: 16302153
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs.
Stokol T; Brooks M; Erb H; Mauldin GE
J Vet Intern Med; 1999; 13(5):478-84. PubMed ID: 10499733
[TBL] [Abstract][Full Text] [Related]
23. Comparability of D-dimer assays in clinical samples.
Freyburger G; Labrouche S
Semin Vasc Med; 2005 Nov; 5(4):328-39. PubMed ID: 16302154
[TBL] [Abstract][Full Text] [Related]
24. An immunoassay for human D dimer using monoclonal antibodies.
Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ
Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576
[TBL] [Abstract][Full Text] [Related]
25. D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases.
Ikeda N; Wada H; Ichikawa Y; Ezaki M; Tanaka M; Hiromori S; Shiraki K; Moritani I; Yamamoto A; Shimpo H; Shimaoka M
Clin Appl Thromb Hemost; 2022; 28():10760296211070584. PubMed ID: 34994210
[TBL] [Abstract][Full Text] [Related]
26. [Studies on the fragments of FDP in 3 non-DIC patients with increased FDP levels in the sera].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Shinoda T; Nakahata T; Saitoh H
Rinsho Byori; 1993 Feb; 41(2):220-6. PubMed ID: 8361025
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
[TBL] [Abstract][Full Text] [Related]
28. Determination of FDP in human plasma by a novel latex immunoassay.
Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K
Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715
[TBL] [Abstract][Full Text] [Related]
29. Reactivity of D-dimer assays with the fibrinogen--fibrin split products generated by thrombolytic agents.
Amiral J; Minard F; Plassart V; Vissac AM; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):525-30. PubMed ID: 2133230
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
31. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
32. [Study on cases of D dimer values were dissociated from FDP-E].
Himizu M; Ishii K; Katagiri H; Saga K; Ono F; Yamamoto M; Todoroki T; Kawai Y; Watanabe K; Iri H
Rinsho Byori; 1991 Mar; 39(3):302-8. PubMed ID: 2051606
[TBL] [Abstract][Full Text] [Related]
33. Use of D-dimer assays in the diagnosis of venous thrombosis.
Dempfle CE
Semin Thromb Hemost; 2000; 26(6):631-41. PubMed ID: 11140800
[TBL] [Abstract][Full Text] [Related]
34. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
35. D-dimer antigen: current concepts and future prospects.
Adam SS; Key NS; Greenberg CS
Blood; 2009 Mar; 113(13):2878-87. PubMed ID: 19008457
[TBL] [Abstract][Full Text] [Related]
36. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; FDP D dimer analysis using NANOPIA FDP].
Matsumoto T; Sakai Y; Maeda M; Takei F
Rinsho Byori; 1989 Apr; Spec No 81():183-8. PubMed ID: 2754806
[No Abstract] [Full Text] [Related]
37. The usefulness of five D-dimer assays in the exclusion of deep venous thrombosis.
Schutgens RE; Haas FJ; Gerritsen WB; van der Horst F; Nieuwenhuis HK; Biesma DH
J Thromb Haemost; 2003 May; 1(5):976-81. PubMed ID: 12871364
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
[TBL] [Abstract][Full Text] [Related]
39. Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.
Moresco RN; Júnior RH; Cláudio Rosa Vargas L; Mariano da Rocha Silla L
J Thromb Thrombolysis; 2006 Apr; 21(2):199-202. PubMed ID: 16622618
[TBL] [Abstract][Full Text] [Related]
40. The clinical utility of fibrin-related biomarkers in sepsis.
Toh JM; Ken-Dror G; Downey C; Abrams ST
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):839-43. PubMed ID: 24030119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
